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Abstract Linear free energy relationships can be used to link
the changes in rate constant for a reaction to changes in the
equilibrium caused by alterations in structure. While they have
most often been used in the analysis of chemical reactions, they
have also been employed to resolve questions in enzymology and
protein folding. Here we analyze the reaction of a serpin with a
panel of six serine proteinases, and observe that a linear free
energy relationship exists between the true second-order rate
constant for reaction, kinh, and the inhibition constant, KI,
indicating that formation of the covalent serpin^enzyme complex
may be reversible. ß 2000 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Serine proteinase inhibitors of the serpin family are struc-
turally homologous proteins whose members play central
roles in the regulation of a wide variety of physiological pro-
cesses including ¢brinolysis, coagulation, in£ammation, fertil-
ization, malignancy, neuromuscular patterning and develop-
ment [1]. While most in the ¢eld now agree on a basic kinetic
and mechanistic model [2], certain details of the mechanism
by which serpins inhibit their target proteinases remain con-
troversial. A powerful tool in the search to understand the
relationship between molecular structure and activity is the
linear free energy relationship (LFER). LFERs link the e¡ect
of a change in structure on the rate constant for a given
reaction to its e¡ect on the equilibrium constant for the
same process [3]. In so doing, LFERs can shed light on the
structure of the transition state for reaction relative to the
reactant and product ground states, and on the role that spe-
ci¢c interactions play in transition state stabilization. LFERs
have primarily been used in the analysis of chemical reactions,
but have increasingly found applications in enzymology, for
example in probing the role of the catalytic lysine in aspartate
aminotransferase [4,5], and in ribulose 1,5-bisphosphate car-
boxylase/oxygenase [6], in determining the mechanism of GTP
hydrolysis by GTP-binding proteins [7^9], in the evaluation of
the reaction mechanism of cytochrome P450 [10^12], and of
energy coupling in the F0F1-ATP synthase reaction [13].
LFERs have also proven to be an invaluable tool in the anal-
ysis of protein folding [14], suggesting that they might be ap-
plicable to the serpin^proteinase inhibition mechanism in
which the rate-limiting step is believed to involve a substantial
conformational rearrangement of the serpin structure [2].
However, to date there has been no example of the applica-
tion of LFERs to the serpin mechanism. In the analysis of the
serpin inhibition mechanism, LFERs may o¡er a unique
glimpse at events occurring in the transition states of key steps
in the reaction, and may thus help resolve questions concern-
ing the nature of these steps. Here we interpret data for the
reaction of the secreted viral serpin SERP-1 with a panel of
six serine proteinases in terms of the interactions that exist
between serpin and enzyme at di¡erent points along the free
energy pro¢le for reaction. We also present the ¢rst demon-
stration that a linear free energy relationship exists between
the true second-order rate constant for reaction, kinh, and the
inhibition constant, KI. This ¢nding lends support to pro-
posals that the formation of the covalent inhibited serpin^
enzyme complex may be reversible.
2. The serpin mechanism
The mechanism for the reaction of a serpin with a target
proteinase, leading to the formation of a covalent inhibited
serpin^proteinase complex, EI*, is incompletely understood.
After extensive study by many groups, the branched reaction
scheme shown in Scheme 1A has become accepted as a min-
imal kinetic mechanism for the reaction [2]. However, the
precise natures of several of the steps in the reaction remain
controversial. In Scheme 1A, enzyme (E) and serpin (I) ini-
tially interact to form a non-covalent Michaelis complex, EI,
in which the reactive center loop (RCL) of the serpin occupies
the active site cleft of the proteinase. The Michaelis complex
then undergoes a reaction involving the catalytic functionality
at the active site of the proteinase, leading to the formation of
a covalent acyl^enzyme intermediate, [EI], in which the
cleaved portion of the RCL has likely become partly inserted
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 6 2 0 - 3
*Corresponding author. Present address: Programme in Molecular
Biology and Cancer, Samuel Lunenfeld Research Institute, Mount
Sinai Hospital, 600 University Avenue, Room 1081, Toronto, Ont.,
Canada M5G 1X5. Fax: (1)-416-586 8869.
E-mail: piers@mshri.on.ca
1 Also corresponding author. Fax: (1)-617-679 3208;
E-mail: adrian_whitty@biogen.com.
FEBS 23747 6-6-00
FEBS 23747 FEBS Letters 475 (2000) 1^6
into L-sheet A of the serpin structure. The intermediate [EI]
can partition to react through two distinct pathways. It can
undergo a conformational rearrangement involving insertion
of the remainder of the cleaved RCL into L-sheet A [2], re-
sulting in a substantial increase in stability of the serpin struc-
ture. This conformational change leads to the ¢nal inhibited
complex, EI*, in which the tethered proteinase has moved to
the opposite pole of the serpin where it interacts with the
serpin structure in such a way that the catalytic machinery
of the enzyme is forced to adopt an inactive conformation.
Alternatively, the intermediate [EI] can undergo hydrolysis,
catalyzed by the proteinase, leading to its deacylation in a
step that resembles the reaction of a proteinase substrate.
The products of deacylation are cleaved serpin, IP, and active
proteinase. The ¢nal inhibited complex, EI*, can also undergo
very slow hydrolysis to release active enzyme and cleaved
serpin (Scheme 1A). Despite broad acceptance of the minimal
kinetic scheme shown in Scheme 1A, numerous details of the
mechanism remain the subjects of uncertainty and debate. For
example, the degree to which the RCL becomes inserted into
L-sheet A prior to RCL cleavage and acyl^enzyme formation
is disputed, with one recent report suggesting that full inser-
tion precedes the acylation that leads to the ¢rst covalent
intermediate [15]. Similarly, one report has suggested that
the ¢nal inhibited complex EI* may have a structure at the
enzyme active site that corresponds to the tetrahedral inter-
mediate that precedes acyl^enzyme formation in the serine
proteinase reaction mechanism [16]. Another contentious issue
concerns the degree to which formation of [EI] and its con-
version to the ¢nal inhibited complex, EI*, is reversible. Sev-
eral reports indicate that uncleaved, reactive serpin can be
recovered from the EI* complex in at least some cases [16^
18], indicating that in these cases all the steps leading to the
formation of EI* must be reversible. Nevertheless, most re-
ports show these steps as irreversible [2,20]. If the formation
of EI* is reversible, even if only very slowly, this raises the
possibility that the slow hydrolysis of EI* to release cleaved
serpin plus active enzyme might occur, in whole or in part,
through the reversion of EI* to [EI] followed by the deacyla-
tion of [EI] via the substrate pathway. It is possible to draw a
kinetic scheme that incorporates some of the additional mech-
anistic possibilities that are raised by these unresolved ques-
tions (Scheme 1B). According to this mechanism, all of the
steps are potentially reversible, though the rate constants
could still heavily bias the reaction in a forward direction.
While the kinetic and mechanistic models in Scheme 1 serve
as an excellent basis for the analysis of serpin^proteinase in-
teractions, it is di⁄cult in practice to directly measure the
kinetic constants for most of the individual microscopic steps
in this mechanism. Instead, we are limited to measuring mac-
roscopic rate constants that in most cases are composite func-
tions of the microscopic rate constants in Scheme 1 [19,21].
For example, the apparent second-order rate constant for re-
action, kapp, is a measure of the overall rate at which a serpin
reacts to form the ¢nal inhibited complex, EI*. However,
because of the branched nature of the reaction pathway,
this number is not identical to the true second-order rate
constant for the reaction between E and I, kinh. This is be-
cause, if only a fraction of [EI] goes on to form EI*, due to
partitioning through the substrate branch of the pathway
(with rate constant k4), then the rate constant for the forma-
tion of EI* will be smaller than that for the formation of [EI]
by a factor of (1+k3/k4) [21]. Similarly, the macroscopically
observed inhibition constant, KIapp, re£ects the steady state
balance between all of the pathways for the formation of
inhibited enzyme species EI, [EI] and EI* and all of the path-
ways for the regeneration of active enzyme, including via the
substrate pathway. In order to determine the true balance
between the formation and decomposition of the ¢nal inhib-
ited complex, EI*, it is again necessary to divide KIapp by a
factor of (1+k3/k4) to compensate for the alternative route to
the regeneration of active enzyme that is provided by parti-
tioning through the substrate branch of the pathway [21].
Fortunately, it is possible to directly determine the partition-
ing ratio, k3/k4, by measuring the stoichiometry of inhibition
(SI), i.e. the number of equivalents of serpin required to fully
inactivate the enzyme under conditions where [I]EKIapp
[21]. This is because the requirement for additional equiva-
lents of serpin to achieve complete inhibition stems directly
from the cleavage of a ¢xed fraction of the serpin by reaction
through the substrate pathway. Finally, the rate constant for
the decomposition of EI* to release active enzyme, kdiss, can
be measured directly. However, in the context of the reversible
kinetic mechanism in Scheme 1B, kdiss represents the sum of
k5+k34 (at least for reactions where SIs 2; for reactions
where SI9 2 kdiss is a more complex function of k5, k34 and
other rate constants).
3. Observation of a linear free energy relationship for the
reactions of SERP-1
An extensive data set, encompassing the reaction of a single
serpin with a panel of six serine proteinases under identical
conditions, is available for the myxoma virus serpin, SERP-1
[22]. SERP-1 is one of many immunomodulatory proteins
Scheme 1. A: Minimal kinetic scheme for the reaction of a serpin,
I, with a proteinase, E, to form a stable, covalent inhibited complex,
EI* (adapted from [2]). Initial formation of the non-covalent Mi-
chaelis complex, EI, is followed by acylation of the enzyme by the
serpin to form the initial acyl^enzyme complex, [EI]. The intermedi-
ate complex [EI] can partition to undergo a conformational rear-
rangement resulting in the formation of the ¢nal inhibited complex,
EI*, or to undergo hydrolytic deacylation to form cleaved serpin
(IP) and release active enzyme, through the ‘substrate pathway’. The
¢nal inhibited complex, EI*, slowly decomposes through a single
pathway, resulting in the release of cleaved serpin and active en-
zyme with rate constant k5. B: Modi¢ed kinetic scheme which in-
corporates the possibility that the steps with rate constants k2 and
k4 might be reversible, and thus that EI* can decompose either
through direct hydrolysis (with rate constant k5), or by the reverse
of its formation, through reversion to [EI]. In a case where active
serpin can be quantitatively recovered from the complex, it must be
true that k34Ek5, and k32Ek3 (see text).
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produced by myxoma virus [23], but has the distinction of
being the only known virus-encoded secreted serpin. SERP-1
serves to dampen the in vivo in£ammatory response to virus
infection [24]. Puri¢ed SERP-1 protein has also been em-
ployed as an e¡ective anti-in£ammatory agent in model sys-
tems relevant to human disease [25,26]. Biochemically, SERP-
1 has been shown to strongly inhibit enzymes of the plas-
minogen cascade such as tissue-type plasminogen activator
(t-PA), urokinase (u-PA) and plasmin [22,27]. It is not clear
yet whether these are in fact the biological targets for SERP-1
that are responsible for its activity in vivo. Values for kapp,
KIapp, kdiss, SI, kinh and KI for the interaction of SERP-1
with urokinase (uPA), tissue-type plasminogen activator
(tPA), plasmin, thrombin, factor Xa, and C1s [22] are shown
in Table 1. For the purposes of this discussion, SERP-1 pro-
vides the most complete set of kinetic data for the reaction of
a single serpin with multiple proteinases.
Fig. 1 shows that a plot of log kinh against log KI, con-
structed using the data from Table 1, reveals the apparent
existence of a linear free energy relationship (LFER) with
slope L=30.7. The observation of such a relationship is
somewhat surprising: KI re£ects the balance between the rates
for the formation and decomposition of EI* which, according
to the minimal kinetic mechanism in Scheme 1A, occur
through unrelated sequential processes. However, the relation-
ship in Fig. 1 implies that the enzyme^serpin interactions and
other factors that are responsible for the variations in kinh
between the di¡erent serpin^enzyme pairs also govern the
magnitude of KI. In contrast, the wide variations in the rela-
tive magnitudes of k3 and k4 among the enzymes listed in
Table 1, and the lack of any relationship between k3/k4 and
kinh or KI, implies that the interactions responsible for dis-
crimination between the enzymes in the transition state for the
k4 step are not related to the interactions leading to variations
among the rates of [EI] deacylation in the k3 step. This con-
clusion is consistent with the belief that the steps with rate
constants k3 and k4 represent quite distinct processes: in one
case, the enzyme-catalyzed deacylation of [EI] to release
cleaved serpin; in the other, a conformational rearrangement
involving insertion of the remaining uninserted portion of the
RCL into L-sheet A of the serpin structure [20], with concom-
itant loss of interaction between the enzyme active site and
serpin residues on the P1P (N-terminal) side of the cleavage
site within the RCL, a substantial change in the geometry of
interaction between the enzyme and residues of the RCL on
the C-terminal side of the cleavage site [2], and possibly also a
distortion of enzyme active site residues themselves [28].
The LFER shown in Fig. 1 is easily understood, however, if
the formation of EI* is truly (if slowly) reversible, as has been
shown for some other serpin^proteinase pairs [17^19]. If this
is correct, then kinh and KI comprise describe the rate and
equilibrium constants for the same process. As such, it would
not be surprising that the interactions that govern the varia-
tions in kinh are retained in the ¢nal inhibited complex, lead-
ing to the observation of an LFER between kinh and KI. In-
deed, the slope of L=30.7 would imply that these interactions
are approximately two-thirds formed in the transition state
for the conformational rearrangement of [EI] relative to their
¢nal state in EI* [29,30].
4. Free energy pro¢les for the serpin^proteinase reaction
The mechanistic signi¢cance of the relationship shown in
Fig. 1, and of the variations in the other rate constants in
Table 1 for the di¡erent serpin^enzyme pairs, can be further
analyzed in terms of their e¡ects on the shape of free energy
pro¢le for the reaction. A free energy pro¢le for the formation
and decomposition of EI* can be constructed under two
di¡erent sets of assumptions, depending on whether the for-
mation of the ¢nal inhibited complex (EI*) from [EI] is con-
sidered to be irreversible (Scheme 1A) or reversible (Scheme
1B). Under case A (Scheme 1A), the conversion of [EI] to EI*
is assumed to be essentially irreversible (i.e. k5Ek34), and
therefore the predominant pathway for the decomposition of
EI* is through its direct hydrolysis with rate constant k5. The
Fig. 1. Linear free energy relationship for the reactions of SERP-1.
Linear free energy relationship between log kinh and log KI based on
the data from Table 1. The solid line represents the best ¢t to the
data for thrombin (b), tPA (E), uPA (O), plasmin (a), Xa (7)
and C1s (F), and has a slope of LV30.7. The error bar on the
data point for C1s indicates the higher position it would occupy if
it were plotted based on the higher value of kapp = 1300 M31 s31 re-
ported by Lomas et al. [27]. Data for C1s were estimated based on
an assumed SI of 2, to give kinh = 600 M31 s31, and KI = 100 nM
[22]; the dashed arrow indicates how the location of the data
point for C1s would change for SI values from 1 (bottom right) to
10 (upper left), which span the likely range for this enzyme [22].
Table 1
Summary Of SERP-1 inhibition kinetics
Enzyme KIapp (nM) kapp (M31 s31) kdiss (s31) SI KI (nM) kinh (M31 s31)
uPA 0.16 5.0U104 8U1036 1.4 0.11 7.0U104
tPA 0.14 4.3U104 7U1036 V2 0.07 8.6U104
Plasmin 0.44 4.8U104 2U1035 2.0 0.22 9.6U104
Thrombin 0.13 2.6U104 3U1036 13 0.01 3.4U105
Factor Xa 4.3 1.7U103 7U1036 3.2 1.3 5.4U103
C1s 200 3U102 6U1035 n.d. V100 V6U102
Kinetic parameters for the reaction of SERP-1 with six inhibited proteinases before and after correction for the e¡ects of partitioning in the
branched kinetic mechanism. The values are as reported in Nash et al. [22].
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formation of [EI] is also assumed to be irreversible, and thus
the partitioning of [EI] through the inhibition and substrate
pathways is fast compared to its formation (i.e. k3, k4Ek32).
The relatively low values observed for kinh are taken to indi-
cate that the chemical step (k2), and not the di¡usional en-
counter of serpin with the proteinase (k1), is the rate-limiting
step in the formation of EI*. These case A assumptions can be
represented in the form of a hypothetical free energy pro¢le
for the serpin^proteinase reaction, as shown in Fig. 2A. Fig.
2A illustrates how the case A assumptions allow the rate
constants kinh and kdiss to be associated with speci¢c activa-
tion barriers in the free energy pro¢le for reaction. The con-
sequences of the variations in kinh and kdiss seen in Table 1 for
the shape of the free energy pro¢le can be analyzed by con-
verting the measured di¡erences in rate constants into di¡er-
ences in the free energy of activation for the appropriate step,
using the expression vGV13vG
V
2 =3RT ln(k1/k2). Applica-
tion of these case A assumptions to the kinetic data in Table 1
thus results in a slightly di¡erent free energy pro¢le for reac-
tion with each enzyme, depending on the values for kinh and
kdiss that were observed in each case. Fig. 2B shows how the
data for reaction with each enzyme in£uence the shape of the
free energy pro¢le, when the kinetic data are interpreted under
the case A assumptions that were derived from Scheme 1A.
Under case B (Scheme 1B), the formation of [EI] and its
conversion to EI* are considered to be reversible. Evidence
exists for several enzyme^serpin systems to suggest that this
description is accurate in at least some cases [17^19,31]. Direct
hydrolysis of EI* is assumed to be very slow, so that the
predominant pathway for the decomposition of EI* is
through the reverse of its formation (i.e. k5Ik34). Under
these assumptions, for interactions where the stoichiometry
of inhibition is relatively low (i.e. where k36V10k4) the for-
mation of [EI] must be fast compared to its partitioning
through the inhibition and substrate pathways (i.e. k32Ek3,
k4). If this were not true, then the reversion of EI* to [EI]
would lead predominantly to the formation of cleaved serpin,
and the recovery of active serpin from the complex [17^19,31]
would not be possible. Thus, under case B assumptions the
rate-limiting step in the formation of EI* is the conversion of
[EI] to EI* with rate constant k4. Adoption of case B assump-
tions therefore corresponds to the free energy pro¢le shown in
Fig. 3A. Application of these assumptions to the kinetic data
in Table 1 produces the overlaid free energy pro¢les shown in
Fig. 3B.
The di¡erences in the speci¢city of SERP-1 for the six in-
hibited proteinases shown in Table 1 are manifested as varia-
tions in the magnitudes of the constants kinh, kdiss, KI and SI.
Because we do not know whether case A or case B best de-
scribes the reactions of SERP-1 with the proteinases that were
tested, application of these two cases leaves us with two dis-
tinct and mutually exclusive interpretations of the data. If case
A is correct (i.e. k34Ik5), then variations in the rate of for-
mation of the ¢nal inhibited complex, EI*, arise from di¡er-
ences in the interactions between the enzyme and SERP-1 in
the transition state for the formation of [EI] (Fig. 2B). This
transition state is presumably that for the chemical step of
acylation of the enzyme by SERP-1. The enzymes uPA,
tPA, plasmin, and thrombin are therefore inactivated very
rapidly because they have more favorable binding interactions
Fig. 2. Free energy pro¢les for the inhibition of serine proteinases by SERP-1 based on the mechanism shown in Scheme 1A. Broken lines indi-
cate energy barriers for irreversible steps, or barriers that cannot be de¢ned using the kinetic constants in Table 1. A: Free energy pro¢le for
the reaction of a proteinase with SERP-1, for the case where the sole pathway for the breakdown of the ¢nal inhibited complex is through the
direct hydrolysis of EI* to release cleaved serpin, with rate constant k5 (Scheme 1A). Under this assumption and its corollaries (collectively re-
ferred to in the text as the ‘case A assumptions’), variations in kinh re£ect di¡erences in the activation barrier for the reaction of E+I to form
[EI], while variations in kdiss re£ect di¡erences in the activation barrier for the deacylation of EI* via the pathway with rate constant k5. The
observed variations in KI re£ect the balance between these two independent processes and, consequently, KI has no intrinsic thermodynamic
signi¢cance (see text). B: Experimental data from Table 1 for the reactions of SERP-1 with thrombin (b), tPA (E), uPA (O), plasmin (a), Xa
(7) and C1s (F), mapped onto a free energy pro¢le of the form shown in A, as described in the text. For clarity, the k3 pathway, which is
shown in A, has been omitted from B. Free energies were calculated from the data in Table 1 using the relation: vGV13vG
V
2 =3RT ln(k1/
k2).
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with SERP-1 in the transition state for this step than do the
more slowly inhibited enzymes factor Xa and C1s. Under
these assumptions, the variations in kdiss re£ect di¡erences in
the activation barrier for the deacylation of EI* via the path-
way with rate constant k5, resulting from some combination
of variations in ground state and transition state stabilities.
Thus, under the case A assumptions, the variations in KI
re£ect the balance between these two independent e¡ects
and, as a consequence, have no intrinsic thermodynamic sig-
ni¢cance and cannot be interpreted to re£ect changes in the
free energy of EI*.
Under the case B assumptions, variations in the rate of the
formation of EI* arise from di¡erences in the interactions
between the enzymes and SERP-1 in the transition state for
the conformational change in which [EI] converts to EI* (Fig.
3B). Variations in KI have a more direct interpretation than
was the instance in case A. KI can now be seen to directly
re£ect di¡erences in the thermodynamic stability of EI*, with
stabilities of these ¢nal inhibited complexes varying over some
5.4 kcal/mol in the order thrombins tPAVplasminV
uPAsXasC1s (Fig. 3B).
Under both case A and case B assumptions, the variations
in SI re£ect variations in the partitioning of [EI] between in-
hibition and substrate pathways. For example, partitioning of
[EI] through the substrate pathway to release cleaved serpin is
much more favorable, relative to the formation of EI*, for
uPA than it is for thrombin.
5. Conclusions and future directions
Examination of Figs. 2B and 3B shows that the LFER seen
in Fig. 1 is fully consistent with the case B assumptions, de-
rived from Scheme 1B, but is harder to reconcile with case A
(Scheme 1A). Fig. 3B shows that if case B is correct, varia-
tions in kinh and KI result from changes in the free energies of
the transition state and product state, relative to the E+I
ground state, for the same microscopic step; that is for the
conversion of [EI] to EI*. The magnitude of the BrÖnsted
coe⁄cient of L=30.7, obtained from the slope of the plot
in Fig. 1, indicates that the variations in transition state stabil-
ity result from di¡erences in enzyme^serpin interactions that
are roughly two-thirds developed in the transition state rela-
tive to their strengths in the ¢nal inhibited complex, EI*. In
contrast, Fig. 2B shows that under case A assumptions the
variations in KI result from di¡erences in enzyme^serpin in-
teractions that occur in two unrelated steps. As such, under
case A assumptions there is little reason to expect a correla-
tion between kinh and KI of the quality that is seen in Fig. 1.
Although, in principle, it is possible to distinguish experimen-
tally whether the step with rate constant k34 or the step with
rate constant k5 represents the predominant pathways for the
breakdown of EI*, and such measurements have been made in
a few cases [19], in practice such experimental tests are quite
di⁄cult. The observation of the linear correlation shown in
Fig. 1 provides support for the case B assumptions that
kdiss = k34, and therefore that KI = k34/kinh, since no correla-
tion between kinh and KI would be expected if KI = k5/kinh, as
is required in case A. Nevertheless, the observation of the
correlation shown in Fig. 1 does not provide conclusive proof
of a thermodynamic link between kinh and KI, and we there-
fore regard the nature of the dissociation pathway in the re-
action to remain an open question.
Fig. 3. Free energy pro¢les for the inhibition of serine proteinases by SERP-1 based on the mechanism in Scheme 1B. Broken lines indicate en-
ergy barriers that cannot be de¢ned using the kinetic constants in Table 1. A: Free energy pro¢le for the reaction of a proteinase with SERP-
1, for the case where the predominant pathway for the breakdown of the ¢nal inhibited complex (under conditions where [SERP-1]freeIKI) is
through reversion to [EI] leading to the release of active serpin (i.e. k5Ik34, and k3Ik32 ; see Scheme 1B). Under these assumptions (collec-
tively referred to in the text as the ‘case B assumptions’), variations in kinh represent variations in the stability of the transition state, relative
to the E+I ground state, for the conversion of [EI] to EI*; and variations in KI re£ect variations in the stability of the ¢nal inhibited complex,
also with respect to the E+I ground state (see text). This set of assumptions is thus consistent with the experimental observation that the varia-
tions in kinh and in KI are quantitatively related through the LFER shown in Fig. 1. B: Experimental data from Table 1 for the reactions of
SERP-1 with thrombin (b), tPA (E), uPA (O), plasmin (a), Xa (7) and C1s (F), mapped onto a free energy pro¢le of the form shown in A,
as described in the text. For clarity, the k3 pathway, which is shown in A, has been omitted from B. Free energies were calculated from the
data in Table 1 using the relations: vGV13vG
V
2 =3RT ln(k1/k2), and vG
Eq
13vG
Eq
2 =3RT ln(K1/K2).
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Regardless of which interpretation on this point is correct,
our results show unequivocally that, although the inhibitory
speci¢city of SERP-1 is substantially in£uenced by variations
in the interactions between enzyme and serpin in the transi-
tion state of the rate-limiting step in the formation of EI*,
speci¢c binding interactions in ground states or transition
states that occur after the rate-limiting step for inhibition
may also play a signi¢cant role. The strength of the interac-
tion between enzyme and serpin in these later complexes, and
also the partitioning between inhibition and substrate path-
ways, may therefore contribute to the inhibitory speci¢city of
serpins that act at concentrations close to their IC50 for inter-
action with a given proteinase, or that are not present in
signi¢cant excess over their proteinase targets, as has been
discussed more fully elsewhere [22]. These conditions may
pertain to the anti-in£ammatory role of SERP-1, as well as
to situations such as the inhibition of intracellular caspases by
crmA or other serpin inhibitors of apoptosis, where the serpin
may be acting at relatively low concentrations.
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